China Substance Abuse Treatment Market Research Report 2017

Publisher Name :
Date: 05-Dec-2017
No. of pages: 99
Inquire Before Buying

The global Substance Abuse Treatment market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Substance Abuse Treatment development status and future trend in China, focuses on top players in China, also splits Substance Abuse Treatment by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- Alkermes

- Allergan

- GSK

- Pfizer

- Accord Healthcare

- Amphastar Pharmaceuticals

- Apotex

- BioCorRx

- Cipla

- Glenmark

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

- Alcohol Abuse Treatment

- Nicotine Abuse Treatment

- Drug Abuse Treatment

On the basis of the end users/application, this report covers

- Hospitals

- Clinics

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

China Substance Abuse Treatment Market Research Report 2017

Table of Contents
China Substance Abuse Treatment Market Research Report 2017
1 Substance Abuse Treatment Overview
1.1 Product Overview and Scope of Substance Abuse Treatment
1.2 Classification of Substance Abuse Treatment by Product Category
1.2.1 China Substance Abuse Treatment Sales (K Units) Comparison by Type (2012-2022)
1.2.2 China Substance Abuse Treatment Sales (K Units) Market Share by Type in 2016
1.2.3 Alcohol Abuse Treatment
1.2.4 Nicotine Abuse Treatment
1.2.5 Drug Abuse Treatment
1.3 China Substance Abuse Treatment Market by Application/End Users
1.3.1 China Substance Abuse Treatment Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 China Substance Abuse Treatment Market by Region
1.4.1 China Substance Abuse Treatment Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.3 East China Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.4 Southwest China Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.5 Northeast China Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.6 North China Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.7 Central China Substance Abuse Treatment Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Substance Abuse Treatment (2012-2022)
1.5.1 China Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
1.5.2 China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 China Substance Abuse Treatment Market Competition by Players/Manufacturers
2.1 China Substance Abuse Treatment Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Substance Abuse Treatment Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Substance Abuse Treatment Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Substance Abuse Treatment Market Competitive Situation and Trends
2.4.1 China Substance Abuse Treatment Market Concentration Rate
2.4.2 China Substance Abuse Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Substance Abuse Treatment Manufacturing Base Distribution, Sales Area, Product Types
3 China Substance Abuse Treatment Sales and Revenue by Region (2012-2017)
3.1 China Substance Abuse Treatment Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Substance Abuse Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Substance Abuse Treatment Price (USD/Unit) by Regions (2012-2017)
4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
4.1 China Substance Abuse Treatment Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Substance Abuse Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Substance Abuse Treatment Price (USD/Unit) by Type (2012-2017)
4.4 China Substance Abuse Treatment Sales Growth Rate (%) by Type (2012-2017)
5 China "&B1&" Sales by Application (2012-2017)"
5.1 China Substance Abuse Treatment Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Substance Abuse Treatment Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 China Substance Abuse Treatment Players/Suppliers Profiles and Sales Data
6.1 Alkermes
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Substance Abuse Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Alkermes Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 Allergan
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Substance Abuse Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 GSK
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Substance Abuse Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GSK Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Substance Abuse Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Accord Healthcare
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Substance Abuse Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Accord Healthcare Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Amphastar Pharmaceuticals
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Substance Abuse Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Apotex
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Substance Abuse Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Apotex Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 BioCorRx
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Substance Abuse Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 BioCorRx Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Cipla
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Substance Abuse Treatment Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cipla Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
6.10 Glenmark
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Substance Abuse Treatment Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Glenmark Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.10.4 Main Business/Business Overview
7 Substance Abuse Treatment Manufacturing Cost Analysis
7.1 Substance Abuse Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Substance Abuse Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Substance Abuse Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Substance Abuse Treatment Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Substance Abuse Treatment Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Substance Abuse Treatment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Substance Abuse Treatment Sales (K Units) Forecast by Type (2017-2022)
11.3 China Substance Abuse Treatment Sales (K Units) Forecast by Application (2017-2022)
11.4 China Substance Abuse Treatment Sales (K Units) Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Substance Abuse Treatment Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Substance Abuse Treatment Sales (K Units) by Application (2016-2022)
Figure Product Picture of Substance Abuse Treatment
Table China Substance Abuse Treatment Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Substance Abuse Treatment Sales Volume Market Share by Types in 2016
Figure Alcohol Abuse Treatment Product Picture
Figure Nicotine Abuse Treatment Product Picture
Figure Drug Abuse Treatment Product Picture
Figure China Substance Abuse Treatment Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Substance Abuse Treatment by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Substance Abuse Treatment Sales of Key Players/Manufacturers (2012-2017)
Table China Substance Abuse Treatment Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Substance Abuse Treatment Sales Share (%) by Players/Manufacturers
Figure 2017 China Substance Abuse Treatment Sales Share (%) by Players/Manufacturers
Table China Substance Abuse Treatment Revenue by Players/Manufacturers (2012-2017)
Table China Substance Abuse Treatment Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Substance Abuse Treatment Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Substance Abuse Treatment Revenue Market Share (%) by Players/Manufacturers
Table China Market Substance Abuse Treatment Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Substance Abuse Treatment Average Price of Key Players/Manufacturers in 2016
Figure China Substance Abuse Treatment Market Share of Top 3 Players/Manufacturers
Figure China Substance Abuse Treatment Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Substance Abuse Treatment Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Substance Abuse Treatment Product Category
Table China Substance Abuse Treatment Sales (K Units) by Regions (2012-2017)
Table China Substance Abuse Treatment Sales Share (%) by Regions (2012-2017)
Figure China Substance Abuse Treatment Sales Share (%) by Regions (2012-2017)
Figure China Substance Abuse Treatment Sales Market Share (%) by Regions in 2016
Table China Substance Abuse Treatment Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Substance Abuse Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Substance Abuse Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure China Substance Abuse Treatment Revenue Market Share (%) by Regions in 2016
Table China Substance Abuse Treatment Price (USD/Unit) by Regions (2012-2017)
Table China Substance Abuse Treatment Sales (K Units) by Type (2012-2017)
Table China Substance Abuse Treatment Sales Share (%) by Type (2012-2017)
Figure China Substance Abuse Treatment Sales Share (%) by Type (2012-2017)
Figure China Substance Abuse Treatment Sales Market Share (%) by Type in 2016
Table China Substance Abuse Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Substance Abuse Treatment Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Substance Abuse Treatment by Type (2012-2017)
Figure Revenue Market Share of Substance Abuse Treatment by Type in 2016
Table China Substance Abuse Treatment Price (USD/Unit) by Types (2012-2017)
Figure China Substance Abuse Treatment Sales Growth Rate (%) by Type (2012-2017)
Table China Substance Abuse Treatment Sales (K Units) by Applications (2012-2017)
Table China Substance Abuse Treatment Sales Market Share (%) by Applications (2012-2017)
Figure China Substance Abuse Treatment Sales Market Share (%) by Application (2012-2017)
Figure China Substance Abuse Treatment Sales Market Share (%) by Application in 2016
Table China Substance Abuse Treatment Sales Growth Rate (%) by Application (2012-2017)
Figure China Substance Abuse Treatment Sales Growth Rate (%) by Application (2012-2017)
Table Alkermes Substance Abuse Treatment Basic Information List
Table Alkermes Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Alkermes Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Alkermes Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Alkermes Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Allergan Substance Abuse Treatment Basic Information List
Table Allergan Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Allergan Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Allergan Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Allergan Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table GSK Substance Abuse Treatment Basic Information List
Table GSK Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure GSK Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure GSK Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure GSK Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Pfizer Substance Abuse Treatment Basic Information List
Table Pfizer Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pfizer Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Pfizer Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Pfizer Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Accord Healthcare Substance Abuse Treatment Basic Information List
Table Accord Healthcare Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Amphastar Pharmaceuticals Substance Abuse Treatment Basic Information List
Table Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Apotex Substance Abuse Treatment Basic Information List
Table Apotex Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Apotex Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Apotex Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Apotex Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table BioCorRx Substance Abuse Treatment Basic Information List
Table BioCorRx Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure BioCorRx Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure BioCorRx Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure BioCorRx Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Cipla Substance Abuse Treatment Basic Information List
Table Cipla Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Cipla Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Cipla Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Cipla Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Glenmark Substance Abuse Treatment Basic Information List
Table Glenmark Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Glenmark Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Glenmark Substance Abuse Treatment Sales Market Share (%) in China (2012-2017)
Figure Glenmark Substance Abuse Treatment Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Substance Abuse Treatment
Figure Manufacturing Process Analysis of Substance Abuse Treatment
Figure Substance Abuse Treatment Industrial Chain Analysis
Table Raw Materials Sources of Substance Abuse Treatment Major Players/Manufacturers in 2016
Table Major Buyers of Substance Abuse Treatment
Table Distributors/Traders List
Figure China Substance Abuse Treatment Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Substance Abuse Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Substance Abuse Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table China Substance Abuse Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure China Substance Abuse Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure China Substance Abuse Treatment Sales Volume Market Share Forecast by Type in 2022
Table China Substance Abuse Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure China Substance Abuse Treatment Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Substance Abuse Treatment Sales Volume Market Share Forecast by Application in 2022
Table China Substance Abuse Treatment Sales (K Units) Forecast by Regions (2017-2022)
Table China Substance Abuse Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Substance Abuse Treatment Sales Volume Share Forecast by Regions (2017-2022)
Figure China Substance Abuse Treatment Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Venous Thromboembolism Therapeutics Market Size, Status and Forecast 2022
    Published: 06-Dec-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Venous Thromboembolism Therapeutics market, analyzes and researches the Venous Thromboembolism Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Johnson & Johnson - Sanofi - Boehringer Ingelheim - Daiichi Sankyo - Bristol-Myers Squibb (BMS) - Bayer HealthCare - Pfizer - Leo Pharma - P......
  • United States Brachytherapy Afterloaders, Brachytherapy Seeds Market Report 2017
    Published: 27-Nov-2017        Price: US 3800 Onwards        Pages: 100
    In this report, the United States Brachytherapy Afterloaders, Brachytherapy Seeds market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), ......
  • Global Substance Abuse Treatment Market Professional Survey Report 2017
    Published: 24-Nov-2017        Price: US 3500 Onwards        Pages: 108
    This report studies Substance Abuse Treatment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Alkermes - Allergan - GSK - Pfizer - Accord Healthc......
  • Global Neuromodulation Market Size, Status and Forecast 2022
    Published: 24-Nov-2017        Price: US 3300 Onwards        Pages: 97
    This report studies the global Neuromodulation market, analyzes and researches the Neuromodulation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Medtronic, Inc. (U.S.) - Boston Scientific Corporation (U.S.) - St. Jude Medical, Inc. (U.S.) - Synapse Biomedical, Inc. (U.S.) - Nevro Corporation (U.S.) - Neurosigma, Inc. (U.S.) - Neuropace,......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Sales Market Report 2017
    Published: 22-Nov-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Brachytherapy Afterloaders, Brachytherapy Seeds market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Brachytherapy Afterloaders, Brachytherapy Seeds for these regions, from 2012 to 2022 (forecast), covering - ......
  • Hypercholesterolemia - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 209
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Pipeline Review, H2 2017, provides an overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape.Hypercholesterolemia arises due to high levels of cholesterol in the blood. These abnormal levels may lead to various diseases especially cardiovascular diseases. Cholesterol deposit in the arteries and may cause the narrowing of blood vessels hence restricting the blood fl......
  • Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2017, provides an overview of the Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorders) pipeline landscape.Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder caused due to a mutation (alteration) of FH from one (affected) parent. Symptoms include xanthesmas, corneal arcus, aortic rupture and periphera......
  • Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 83
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2017, provides an overview of the Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape.Homozygous familial hypercholesterolemia is a genetic disorder which is caused due to mutation from both parents. HoFH causes LDL cholesterol level to be very high. Symptoms include xanthelasmas, chest pain and sores on ......
  • Axial Spondyloarthritis - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 104
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Pipeline Review, H2 2017, provides an overview of the Axial Spondyloarthritis (Musculoskeletal Disorders) pipeline landscape.Axial spondylitis is a type of inflammatory arthritis involving the spine and/or sacroiliac joints. Axial spondylitis is strongly related to the presence of the HLA-B27 gene. A genetic test for HLA-B27 is available.Report HighlightsGlobal ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs